Products
TEMPO Platform | Tune Therapeutics
Service description
Tune Therapeutics’ proprietary TEMPO platform enables precise epigenetic control, allowing for the activation, silencing, and fine-tuning of gene expression without altering the DNA sequence. This technology has the potential to target a wide range of diseases, including cancer, genetic disorders, and age-related conditions.